Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma

Hong Chang, Young Trieu, Xiaoying Qi, Wei Xu, Keith A. Stewart, Donna Reece

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Fingerprint Dive into the research topics of 'Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences